The epidemiology of interstitial lung diseases

American Journal of Respiratory and Critical Care Medicine

Volumn 150, Issue 4, 1994, Pages 967-972

  Coultas, David B ^a   Zumwalt, Ross E ^b   Black, William C ^b   Sobonya, Richard E ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0028020387     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.150.4.7921471     Document Type: Article

References (35)

1. Crystal RG, Gadek JE, Ferrans VJ, Fulmer JD, Line BR, Hunninghake GW. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med 1981;70:542-68.
2. National Institutes of Health, Division of Lung Diseases, National Heart, Lung, and Blood Institute: Report of task force on epidemiology of respiratory diseases. Washington, DC: U.S. Department of Health and Human Services, 1980. NIH Publication No. 81-2019.
3. U.S. Department of Health, Education, and Welfare. Respiratory Diseases Task Force: Report on problems, research, approaches, and needs. Washington, DC: U.S. Government Printing Office;1972, 1976 (October 1976). DHEW Publication No. NIH 76-432.
4. Cherniack RM, Crystal RG, Kalica AR. NHLBI Workshop summary. Current concepts in idiopathic pulmonary fibrosis: a road map for the future. Am Rev Respir Dis 1991;143:680-3.
5. Bureau of Business and Economic Research, University of New Mexico. The Census in New Mexico: population and housing characteristics for the state and counties from the 1980 and 1990 Censuses. Albuquerque, NM: Bureau of Business and Economic Research, University of New Mexico, 1992.
6. American Hospital Association guide to the health care field. Chicago, IL: American Hospital Association, 1986.
7. World Health Organization. International classification of disease. Manual of the international classification of diseases, injuries, and causes of death-clinical modification. Geneva: World Health Organization, 1979.
8. U.S. Department of Commerce, Bureau of the Census. 1980 Census of population, volume 1, characteristics of the population. Chapter B, general population characteristics. Part 1, United States summary, PC80 1 B1, May 1983.
9. U.S. Department of Commerce, Bureau of the Census. 1990 Census of population and housing. Summary tape file 1C.
10. Rothman KJ. Modern epidemiology, Boston: Little, Brown, 1986.
11. SAS Institute Inc. SAS User's guide: statistics, version 6. Cary, NC: SAS Institute, 1990.
12. Williams JL, ed. New Mexico in maps. 2nd ed. Albuquerque, NM: University of New Mexico Press, 1986.
13. Lebowitz MD, Burrows B. Tucson epidemiologic study of obstructive lung diseases. II. Effects of in-migration factors on the prevalence of obstructive lung diseases. Am J Epidemiol 1975;102:153-63.
14. Kawanami O, Basset F, Barrios R, Lacronique JG, Ferrans VJ, Crystal RG. Hypersensitivity pneumonitis in man. Light and electron microscopic studies of 18 lung biopsies. Am J Pathol 1983;110:275-89.
15. Myers JL, Veal CF, Shin MS, Katzenstein AA. Respiratory bronchiolitis causing interstitial lung disease. Am Rev Respir Dis 1987;135:880-4.
16. Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989;64:1373-80.
17. Nada AK, Torres VE, Ryu JH, Lie JT, Holley KE. Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc 1990;65:847-56.
18. King TE. Connective tissue disease. In: Schwartz MI, King TE, eds. Interstitial lung disease. St. Louis: Mosby Year Book, 1993:271-308.
19. Gaensler KEA, Jederlinic PJ, Churg A. Idiopathic pulmonary fibrosis in asbestos-exposed workers. Am Rev Respir Dis 1991;144:689-96.
20. DeRemee RA. Clinical profiles of diffuse interstitial pulmonary disease. New York: Futura, 1990.
21. King TE. Idiopathic pulmonary fibrosis. In: Schwarz MI, King TE, eds. Interstitial lung disease. St. Louis: Mosby Year Book, 1993:367-403.
22. Raghu G. Idiopathic pulmonary fibrosis: a rational clinical approach. Chest 1987;92:148-54.
23. U.S. Department of Health and Human Services. The health consequences of smoking. Cancer and chronic lung disease in the workplace. A report of the Surgeon General. Washington, DC: U.S. Government Printing Office, 1985. DHHS (PHS) Publication No. 85-50207.
24. Bresnitz EA, Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev 1983;5:124-56.
25. Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984;310: 154-66, 235-44.
26. Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. Br Med J 1990;301:1015-7.
27. U.S. Department of Health and Human Services. Vital and health statistics. National hospital discharge survey: annual summary, 1988. Hyattsville, MD: DHHS, 1991. No. (PHS) 91-1101.
28. U.S. Department of Health and Human Services. Vital statistics of the United States 1988. Vol. II - Mortality, Part A.
29. Epler GR, Carrington CB, Gaensler EA. Crackles (rales) in the interstitial pulmonary diseases. Chest 1978;73:333-9.
30. Epler GR, McLoud TC, Gaensler EA, Mikus JP, Carrington CB. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 1978;298:934-9.
31. Schwartz DA, Merchant RK, Helmers RA, Gilbert SR, Dayton CS, Hunninghake GW. The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991; 144:504-6.
32. Johnston I, Bleasdale C, Hind CRK, Woodcock AA. Cryptogenic fibrosing alveolitis (CFA): accuracy of diagnostic coding in hospital admissions. Thorax 1989;44:871-2.
33. Johnston I, Britton J, Kinnear W, Logan R. Rising mortality from cryptogenic fibrosing alveolitis. Br Med J 1990;301:1017-21.
34. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35:171-80.
35. Coultas DB. Epidemiology of idiopathic pulmonary fibrosis. Semin Resp Med 1993;14:181-95.